TCM
KERX

Traynor Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Traynor Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,500
Closed -$55K – 142
2016
Q3 		$55K Buy
+12,500
New +$55K 0.04% 123